Hitachi Launches Expanded HMAX Solutions Accelerating Social Innovation Globally Across Industries
6.1.2026 12:30:00 EET | Business Wire | Press release
Hitachi, Ltd. (TSE:6501, "Hitachi") today introduced HMAX by Hitachi at CES 2026. HMAX by Hitachi is a suite of next-generation solutions that brings the power of AI to social infrastructure. By harnessing vast data from physical and digital assets, integrating advanced AI, and applying Hitachi’s unmatched domain expertise, HMAX tackles the most complex social infrastructure challenges—maximizing outcomes and value for our clients and society. These solutions are derived from the formalized HMAX design principles, integrating a dynamic collection of advanced technologies and a robust partner ecosystem that helps elevate end-system reliability and performance.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106885363/en/
HMAX by Hitachi: the suite of next-generation solutions that brings the power of AI to social infrastructure.
HMAX combines data collected from physical and digital assets such as sensors, industrial equipment, and machinery with Hitachi’s domain knowledge accumulated through years of deploying operations and maintenance systems. Advanced AI technologies—i.e., perception AI, generative AI, agentic AI, and physical AI—are then applied to deliver new powerful solutions to organizations worldwide.
Hitachi’s portfolio of HMAX solutions has expanded across three key categories that will truly benefit from the power of AI:
- HMAX Mobility: Powering smarter, better optimized transportation systems, autonomous operations, and IoT-enabled mobility.
- HMAX Energy: Helping ensure secure, reliable, and sustainable operation of mission-critical energy infrastructure across the entire value chain. Through a suite of digitally enabled services, HMAX Energy predicts and prevents issues before they arise—maximizing uptime, extending asset lifetime, and optimizing performance and efficiency.
- HMAX Industry: Advancing safety, productivity, quality, and environmental sustainability in buildings and factories, driving innovation for frontline workers and improving people’s wellbeing.
Hitachi plans to extend HMAX into other mission‑critical domains such as data centers and financial institutions.
Bringing the Power of AI into the Physical World
Labor shortages and aging equipment challenges are increasingly more severe in physical domains like manufacturing and social infrastructure. Physical AI addresses these problems by collecting, analyzing, and operationalizing field data in real-time. Whereas traditional AI focuses primarily on information and creative generation, physical AI creates value in the tangible world through applications such as predictive maintenance, complex systems optimization, robotics and more. As such, the physical AI market is expected to reach approximately 124.77 billion USD by 2030.*1
Hitachi’s strengths in technology, data, and management of physical systems align perfectly with the world of physical AI. Drawing on over 110 years of OT experience and accumulated domain knowledge in mission-critical fields such as railways, energy, and manufacturing, Hitachi is uniquely positioned to bring the next generation of AI-powered solutions to the physical world.
"Hitachi is advancing its vision of ‘Lumada 3.0,’ which aims to lead social innovation to the next stage by integrating domain knowledge with AI,” said Jun Abe, Executive Vice President of Hitachi, Ltd., General Manager of the Digital Systems & Services Division. "HMAX is the realization of this vision, and as a true ‘One Hitachi’ initiative that transcends sector boundaries, we will bring together the collective wisdom and technology of the entire group to create unprecedented synergies. By transforming field data into actionable intelligence through advanced AI, we will powerfully drive the resolution of complex social challenges and deliver tangible value that supports the next generation of social infrastructure.”
Jun Taniguchi, Senior Vice President and Executive Officer, CEO of the Strategic SIB Business Unit at Hitachi, Ltd., added, “For many years, Hitachi has worked alongside customers in the field, overcoming numerous challenges together. Through HMAX, we aim to empower people and infrastructure, unlocking the latent potential of individuals and society. For example, HMAX delivers innovative solutions to our customers’ most complex challenges, such as enhancing operations in railway and manufacturing sites facing shortages of skilled workers and ensuring stable operation of power grids essential for the introduction of renewable energy. With the expansion of HMAX, we are pleased to take a step forward together with our customers toward realizing a harmonized society where the environment, wellbeing, and economic growth are in balance.”
HMAX Design Principles
HMAX is built on four pillars that help customers apply AI to solve problems in physical environments:
- Data from Digitalized Assets: Assets such as power grids, railways, and manufacturing equipment generate vast amounts of data that feed into HMAX datasets—creating the ideal foundation for AI which enables HMAX’s capabilities. This is a unique strength that only Hitachi, with its formidable global install-base, can deliver.
- Domain Knowledge: Hitachi’s deep domain expertise in these physical systems is applied to the data—creating mission-appropriate AI-ready models.
- Artificial Intelligence: HMAX is designed to leverage a range of AI technologies, from data recognition to insight generation to autonomous execution. For example, perception AI detects and reports railway infrastructure faults by analyzing acoustic and vibration sensor data. Generative AI is used to accelerate energy optimization algorithms for power grids. Agentic AI is used to autonomously plan and execute optimal maintenance schedules. And finally, physical AI can control power grids or smart building systems reacting to inputs in real time.
- Partner Ecosystem: HMAX solutions are created using Hitachi’s wide-ranging partner ecosystem—bringing state-of-the-art technology from industry leaders to create robust and dependable solutions that withstand the rigors of the physical world.
HMAX Use Cases and Deployments
The expansion of HMAX across multiple domains is already delivering tangible results.
HMAX Mobility |
Currently deployed on 2,000+ trains, HMAX was first introduced by Hitachi Rail in 2024 as a comprehensive digital asset management solution seamlessly integrating a vast array of live data from the train, signaling and surrounding rail infrastructure into a single platform.*2
|
HMAX Energy |
HMAX Energy combines advanced digital capabilities with extensive domain knowledge, service excellence and installed base intelligence to ensure reliable, efficient energy infrastructure.
|
HMAX Industry |
HMAX for Buildings enhances building operation, maintenance, and energy efficiency while also improving the wellbeing of residents, office workers, and visitors with NVIDIA Metropolis VSS Blueprint. Since 2025, Hitachi has provided digital services—including access control and HVAC management—as a service, supporting building safety, security, and comfort. These outcomes generate optimal building environments while sustainably improving a building’s value.*3
|
CES 2026 Exhibition
Hitachi will exhibit at CES 2026, January 6 to 9, at the Las Vegas Convention Center.*6 HMAX, the centerpiece of Hitachi’s CES experience, will be showcased with live demonstrations at Booth 8529 in the North Hall. Hitachi will also detail its HMAX vision during the CES Foundry session Pioneering AI Technologies for the Physical World on Thursday, January 8 at 11 a.m. PT at The Fontainebleau (Discovery Stage).
To learn more about HMAX by Hitachi, visit www.hitachi.com/en-us/insights/hmax/.
About Hitachi, Ltd.
Through its Social Innovation Business (SIB) that brings together IT, OT (Operational Technology) and products, Hitachi contributes to a harmonized society where the environment, wellbeing, and economic growth are in balance. Hitachi operates globally in four sectors – Digital Systems & Services, Energy, Mobility, and Connective Industries – and the Strategic SIB Business Unit for new growth businesses. With Lumada at its core, Hitachi generates value from integrating data, technology and domain knowledge to solve customer and social challenges. Revenues for FY2024 (ended March 31, 2025) totaled 9,783.3 billion yen, with 618 consolidated subsidiaries and approximately 280,000 employees worldwide. Visit us at www.hitachi.com.
Trademark Notice: All trademarks and product names are the property of their respective owners.
*1 Grand View Research, Inc., Artificial Intelligence in Robotics Market (2024 – 2030), cited as the reference for the market size of AI-powered robots.
*2 Hitachi Rail Unveils the ‘HMAX’ AI Solution, Accelerated by NVIDIA, to Optimize Trains, Signaling and Infrastructure: September 24, 2024
*3 Launch of Hitachi's Digital Service, HMAX for Building: BuilMirai, as an as-a-Service Type that Transforms the Value of Buildings Beginning with a Harmonized Society: September 29, 2025
*4 Through Collaborative Creation, Daikin and Hitachi Begin Trial Operation of AI Agent Supporting Equipment Failure Diagnostics in Factories: April 22, 2025
*5 Hitachi Industrial Equipment Systems Launching AI Agent Service, Part of HMAX Industry, to Help Industrial Workers with Machine Maintenance: December 22, 2025
*6 Hitachi at CES 2026: Building a Harmonized Society Through Technology: December 4, 2025
View source version on businesswire.com: https://www.businesswire.com/news/home/20260106885363/en/
Contacts
Media Contacts
Hiroko Motomura
Hitachi, Ltd.
hiroko.motomura.qc@hitachi.com
Heather Ailara
Hitachi Digital (North America and Europe)
heather@211comms.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 17:18:00 EEST | Press release
Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522186975/en/ Adam Plich, CEO and Co-Founder of Avanzanite Bioscience. “Thalassaemia is a complex, chronic and multisystem disease characterised by anaemia, ineffective erythropoiesis and haemo
ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 15:30:00 EEST | Press release
OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future
Enhertu ® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority
Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 14:45:00 EEST | Press release
Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, signalling a shift in health systems from late-stage treatment to earlier intervention. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522587414/en/ Selected from 393 submissions across 68 countries, the winning teams were recognised through the inaugural ‘Future Health Challenge 2026: Building Anticipatory Health Systems through Population Sensing’, delivered by Future Health – A Global Initiative by Abu Dhabi in collaboration with MIT Solve. Health systems globally are facing rising costs and persistent delays in diagnosis, with many conditions still identified only after symptoms become severe. At the sam
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom